General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0AANWG
ADC Name
PLBC-002
Synonyms
PLBC 002; PLBC002
   Click to Show/Hide
Organization
PrimeLink BioTherapeutics (Suzhou) Co., Ltd.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Triple negative breast cancer
Investigative
.
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed